首页> 外文期刊>Frontiers in Pediatrics >Commentary: Raw Cow Milk Consumption and Atopic March
【24h】

Commentary: Raw Cow Milk Consumption and Atopic March

机译:评论:生牛奶消费和应地行3月

获取原文
           

摘要

We have appreciated the interest of Dr Baars et al. in our paper describing dietary prevention of atopic march (AM) in children affected by cow milk allergy (CMA) (1). They claimed a lack of information on raw cow milk (unpasteurized cow milk) in our paper. In support of this point, they mentioned the result of a pilot study involving nine CMA children (2) that were able to tolerate up to 50 mL of raw milk (about 1,750 mg of cow milk proteins). This result was not confirmed by a similar study where five children with IgE-mediated CMA were orally challenged in a doubleblind fashion with raw untreated cow milk, pasteurized cow milk, and homogenized/pasteurized cow milk. An extensively hydrolysed casein formula served as placebo. All patients presented significant allergic reactions from the consumption of the above three types of milk, whereas no adverse reactions to placebo were observed. The authors concluded that children with CMA cannot tolerate raw or pasteurized milk (3). Although, selected components of raw milk may potentially influence the immune system, proof based on controlled studies in children are still lacking (4). The authors of the PARSIFAL study concluded that raw cow milk may contain numerous diseasecausing pathogens and that consumption of raw milk cannot be recommended as a preventive measure for allergy (5). Accordingly, none of the claims made by the raw milk advocates (including the postulated preventive effect against allergy) withstand the FDA scientific scrutiny (6).
机译:我们赞赏Baars等人博士的兴趣。在我们的论文中,描述了受牛奶过敏(CMA)影响的儿童的膳食预防(AM)(1)。他们声称在我们的论文中缺乏有关生牛奶(未经腐烂的牛奶)的信息。为了支持这一点,他们提到了涉及九个CMA儿童(2)的试验研究的结果,该儿童能够耐受多达50毫升的生乳(约1,750毫克牛奶蛋白)。该结果未得到类似的研究证实,其中5名患有IgE介导的CMA的儿童以双卷发时尚口服挑战,用未经处理的牛奶,巴氏杀菌的牛奶和均质/巴氏牛奶均匀。一种广泛的水解酪蛋白配方配方用作安慰剂。所有患者均出现出于上述三种牛奶的消耗的显着过敏反应,而观察到对安慰剂的不良反应。作者得出结论,CMA的儿童不能忍受原料或巴氏杀菌牛奶(3)。虽然,原料牛奶的选定组分可能会影响免疫系统,但基于儿童的受控研究的证据仍然缺乏(4)。鉴定性研究的作者得出结论,原料牛奶可能含有许多减少病原体,不能建议原料乳的消耗作为过敏(5)的预防措施。因此,未经生牛奶倡导者(包括对抗过敏的假期预防效果)并非妨碍FDA科学审查(6)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号